The neuroplasticity market covers products and therapies that aim to enhance cognitive skills and mental abilities. Neuroplasticity refers to the ability of neural pathways and synapses in the brain to change and adapt as a result of learning and experience. Neuroplasticity-based products include brain training apps, memorization games, physical exercise routines, musical instrument learning programs, cognitive behavioral therapies and more. These products work by stimulating neurogenesis or formation of new neural connections in the brain. The increased connectivity helps strengthen useful pathways and remove inefficient ones. This enhances cognitive functions like memory, attention, critical thinking and problem-solving skills. The global neuroplasticity market is estimated to be valued at US$ 6.61 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The rising prevalence of lifestyle diseases and mental health disorders have increased the need for neuroplasticity-based interventions that can potentially improve symptoms and enhance quality of life. For example, research has found products and therapies aiming at neuroplasticity are effective in reducing depression and managing Alzheimer's disease. As chronic diseases become more common worldwide due to aging populations and stressful lifestyles, the demand for neuroplasticity-enhancing solutions is expected to grow substantially. Leveraging neuroplasticity promises new approaches for optimization of cognitive health in the coming years. This presents a major market opportunity for companies offering innovative apps, programs and therapies in this field to meet the growing need for solutions enhancing mental wellness through neuroplastic rewiring.
Porter's Analysis
Threat of new entrants: The neuroplasticity market is growing at a rapid pace due to increasing prevalence of neurological disorders. However, the market requires huge capital investments and stringent regulations pose high entry barriers for new players.
Bargaining power of buyers: There exists a large patient pool suffering from neurological disorders. However, the specialized nature of products and services limits the bargaining power of buyers.
Bargaining power of suppliers: Key raw material suppliers include active pharmaceutical ingredients and medical device component manufacturers. Suppliers have moderate bargaining power due to availability of substitution.
Threat of new substitutes: Alternative treatment options are available for certain neurological conditions. However, neuroplasticity offers patients renewed hope in recovering lost functions.
Competitive rivalry: The market is dominated by few global players investing heavily in R&D. However, small local players also strive to develop cost effective solutions.
SWOT Analysis
Strengths: Growing prevalence of neurological conditions, rapid technological advancements.
Weaknesses: High costs associated, low awareness in developing nations.
Opportunities: Emerging economies with large patient population, scope for developing affordable therapies.
Threats: Stringent regulatory norms, threat from alternative treatment options.
Key Takeaways
The Global Neuroplasticity Market Size is expected to witness high growth during the forecast period of 2023-2030. North America currently dominates the neuroplasticity market owing to growing awareness, robust healthcare infrastructure and dominance of key market players in the region. The Asia Pacific region is expected to grow at the fastest pace over the coming years.
Regional analysis: The Asia Pacific region has emerged as a major contributor to the growth of global neuroplasticity market. Rising geriatric population, growing research initiatives, and improving healthcare facilities are driving the regional growth. China and India are expected to offer lucrative opportunities with their huge patient base and increasing per capita incomes.
Key players: Key players operating in the Neuroplasticity market are Cushman & Wakefield, Tenon Group, Apollo Sindoori, Compass Group PLC, Sodexo, Serco Group PLC, OCS Group, Jones Lang LaSalle, ISS World Services AS, Ecolab Inc., ABM Industries Inc., Aramark Corporation, and Medxcel Facilities Management, among others.
Get More Insights Here
https://www.trendingwebwire.com/neuroplasticity-market-size-share-growth-outlook-2023/
Comments
0 comment